“…Andraedis et al found that both BCA and BCAC had similar architectural and cytologic factors and were not differentiable by ultrastructural or immunohistochemical examinations [8]. However, other researchers have found certain immunohistochemical markers that may play a role in the diagnosis of BCAC (Table I) [3,4,5]. It is important to distinguish BCAC from other lesions such as basal cell adenoma, basaloid squamous cell carcinoma, myoepithelial lesions, Warthin tumour, pleomorphic adenoma, small cell undifferentiated carcinoma, metastatic adenocarcinoma and adenoid cystic carcinoma due to the difference in treatment and prognosis among these lesions [3,4,5,9].…”